APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tenofovir Disoproxil Fumarate

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tenofovir Disoproxil Fumarate Industry Research Report 2026

Report ID 173874680523 December 2025132 pages

Choose your research edition.

Industry ResearchTenofovir Disoproxil Fumarate Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Tenofovir Disoproxil Fumarate Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Tenofovir Disoproxil Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tenofovir Disoproxil Fumarate Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Tenofovir Disoproxil Fumarate Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Tenofovir Disoproxil Fumarate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tenofovir Disoproxil Fumarate is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tenofovir Disoproxil Fumarate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tenofovir Disoproxil Fumarate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tenofovir Disoproxil Fumarate include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tenofovir Disoproxil Fumarate market in revenue (US$ million) and, where applicable, sales volume (w pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/w pcs) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Tenofovir Disoproxil Fumarate.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tenofovir Disoproxil Fumarate Market by Company

Abbott

Qilu Pharmaceutical

Mylan Pharmaceuticals

Glaxo SmithKline

Chengdu Brilliant Pharmaceutical

Zydus Cadila

Wockhardt Ltd

Torrent Pharmaceuticals

Natco Pharma

Hetero Drugs

Gilead PHARMACARE

Emcure Pharmaceuticals

Dr Reddy's Laboratories

Cipla

CHIA TAI TIANQING (CTTQ) Pharmaceutical

Anhui Biochem Pharmaceutical

Tenofovir Disoproxil Fumarate Segment by Type

30 Pcs/Box

10 Pcs/Box

Tenofovir Disoproxil Fumarate Segment by Application

HIV-1 Infection

Chronic Hepatitis

Others

Tenofovir Disoproxil Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenofovir Disoproxil Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tenofovir Disoproxil Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenofovir Disoproxil Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tenofovir Disoproxil Fumarate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tenofovir Disoproxil Fumarate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tenofovir Disoproxil Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tenofovir Disoproxil Fumarate Production by Manufacturers (w pcs) & (2021-2026) Table 6. Global Tenofovir Disoproxil Fumarate Production Market Share by Manufacturers Table 7. Global Tenofovir Disoproxil Fumarate Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Tenofovir Disoproxil Fumarate Average Price (US$/pcs) of Manufacturers (2021-2026) Table 10. Global Tenofovir Disoproxil Fumarate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tenofovir Disoproxil Fumarate Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Tenofovir Disoproxil Fumarate Manufacturers, Product Type & Application Table 13. Global Tenofovir Disoproxil Fumarate Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tenofovir Disoproxil Fumarate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Abbott Company Information Table 18. Abbott Business Overview Table 19. Abbott Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 20. Abbott Tenofovir Disoproxil Fumarate Product Portfolio Table 21. Abbott Recent Development Table 22. Qilu Pharmaceutical Company Information Table 23. Qilu Pharmaceutical Business Overview Table 24. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 25. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 26. Qilu Pharmaceutical Recent Development Table 27. Mylan Pharmaceuticals Company Information Table 28. Mylan Pharmaceuticals Business Overview Table 29. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 30. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 31. Mylan Pharmaceuticals Recent Development Table 32. Glaxo SmithKline Company Information Table 33. Glaxo SmithKline Business Overview Table 34. Glaxo SmithKline Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 35. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Portfolio Table 36. Glaxo SmithKline Recent Development Table 37. Chengdu Brilliant Pharmaceutical Company Information Table 38. Chengdu Brilliant Pharmaceutical Business Overview Table 39. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 40. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 41. Chengdu Brilliant Pharmaceutical Recent Development Table 42. Zydus Cadila Company Information Table 43. Zydus Cadila Business Overview Table 44. Zydus Cadila Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Zydus Cadila Tenofovir Disoproxil Fumarate Product Portfolio Table 46. Zydus Cadila Recent Development Table 47. Wockhardt Ltd Company Information Table 48. Wockhardt Ltd Business Overview Table 49. Wockhardt Ltd Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 50. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Portfolio Table 51. Wockhardt Ltd Recent Development Table 52. Torrent Pharmaceuticals Company Information Table 53. Torrent Pharmaceuticals Business Overview Table 54. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 55. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 56. Torrent Pharmaceuticals Recent Development Table 57. Natco Pharma Company Information Table 58. Natco Pharma Business Overview Table 59. Natco Pharma Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 60. Natco Pharma Tenofovir Disoproxil Fumarate Product Portfolio Table 61. Natco Pharma Recent Development Table 62. Hetero Drugs Company Information Table 63. Hetero Drugs Business Overview Table 64. Hetero Drugs Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 65. Hetero Drugs Tenofovir Disoproxil Fumarate Product Portfolio Table 66. Hetero Drugs Recent Development Table 67. Gilead PHARMACARE Company Information Table 68. Gilead PHARMACARE Business Overview Table 69. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 70. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Portfolio Table 71. Gilead PHARMACARE Recent Development Table 72. Emcure Pharmaceuticals Company Information Table 73. Emcure Pharmaceuticals Business Overview Table 74. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 75. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 76. Emcure Pharmaceuticals Recent Development Table 77. Dr Reddy's Laboratories Company Information Table 78. Dr Reddy's Laboratories Business Overview Table 79. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 80. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Portfolio Table 81. Dr Reddy's Laboratories Recent Development Table 82. Cipla Company Information Table 83. Cipla Business Overview Table 84. Cipla Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 85. Cipla Tenofovir Disoproxil Fumarate Product Portfolio Table 86. Cipla Recent Development Table 87. CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information Table 88. CHIA TAI TIANQING (CTTQ) Pharmaceutical Business Overview Table 89. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 90. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 91. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development Table 92. Anhui Biochem Pharmaceutical Company Information Table 93. Anhui Biochem Pharmaceutical Business Overview Table 94. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Production (w pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 95. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 96. Anhui Biochem Pharmaceutical Recent Development Table 97. Global Tenofovir Disoproxil Fumarate Production Comparison by Region: 2021 VS 2025 VS 2032 (w pcs) Table 98. Global Tenofovir Disoproxil Fumarate Production by Region (2021-2026) & (w pcs) Table 99. Global Tenofovir Disoproxil Fumarate Production Market Share by Region (2021-2026) Table 100. Global Tenofovir Disoproxil Fumarate Production Forecast by Region (2027-2032) & (w pcs) Table 101. Global Tenofovir Disoproxil Fumarate Production Market Share Forecast by Region (2027-2032) Table 102. Global Tenofovir Disoproxil Fumarate Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Global Tenofovir Disoproxil Fumarate Production Value by Region (2021-2026) & (US$ Million) Table 104. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Region (2021-2026) Table 105. Global Tenofovir Disoproxil Fumarate Production Value Forecast by Region (2027-2032) & (US$ Million) Table 106. Global Tenofovir Disoproxil Fumarate Market Average Price (US$/pcs) by Region (2021-2026) Table 107. Global Tenofovir Disoproxil Fumarate Market Average Price (US$/pcs) by Region (2027-2032) Table 108. Global Tenofovir Disoproxil Fumarate Consumption Comparison by Region: 2021 VS 2025 VS 2032 (w pcs) Table 109. Global Tenofovir Disoproxil Fumarate Consumption by Region (2021-2026) & (w pcs) Table 110. Global Tenofovir Disoproxil Fumarate Consumption Market Share by Region (2021-2026) Table 111. Global Tenofovir Disoproxil Fumarate Forecasted Consumption by Region (2027-2032) & (w pcs) Table 112. Global Tenofovir Disoproxil Fumarate Forecasted Consumption Market Share by Region (2027-2032) Table 113. North America Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (w pcs) Table 114. North America Tenofovir Disoproxil Fumarate Consumption by Country (2021-2026) & (w pcs) Table 115. North America Tenofovir Disoproxil Fumarate Consumption by Country (2027-2032) & (w pcs) Table 116. Europe Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (w pcs) Table 117. Europe Tenofovir Disoproxil Fumarate Consumption by Country (2021-2026) & (w pcs) Table 118. Europe Tenofovir Disoproxil Fumarate Consumption by Country (2027-2032) & (w pcs) Table 119. Asia Pacific Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (w pcs) Table 120. Asia Pacific Tenofovir Disoproxil Fumarate Consumption by Country (2021-2026) & (w pcs) Table 121. Asia Pacific Tenofovir Disoproxil Fumarate Consumption by Country (2027-2032) & (w pcs) Table 122. South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (w pcs) Table 123. South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption by Country (2021-2026) & (w pcs) Table 124. South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption by Country (2027-2032) & (w pcs) Table 125. Global Tenofovir Disoproxil Fumarate Production by Type (2021-2026) & (w pcs) Table 126. Global Tenofovir Disoproxil Fumarate Production by Type (2027-2032) & (w pcs) Table 127. Global Tenofovir Disoproxil Fumarate Production Market Share by Type (2021-2026) Table 128. Global Tenofovir Disoproxil Fumarate Production Market Share by Type (2027-2032) Table 129. Global Tenofovir Disoproxil Fumarate Production Value by Type (2021-2026) & (US$ Million) Table 130. Global Tenofovir Disoproxil Fumarate Production Value by Type (2027-2032) & (US$ Million) Table 131. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Type (2021-2026) Table 132. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Type (2027-2032) Table 133. Global Tenofovir Disoproxil Fumarate Price by Type (2021-2026) & (US$/pcs) Table 134. Global Tenofovir Disoproxil Fumarate Price by Type (2027-2032) & (US$/pcs) Table 135. Global Tenofovir Disoproxil Fumarate Production by Application (2021-2026) & (w pcs) Table 136. Global Tenofovir Disoproxil Fumarate Production by Application (2027-2032) & (w pcs) Table 137. Global Tenofovir Disoproxil Fumarate Production Market Share by Application (2021-2026) Table 138. Global Tenofovir Disoproxil Fumarate Production Market Share by Application (2027-2032) Table 139. Global Tenofovir Disoproxil Fumarate Production Value by Application (2021-2026) & (US$ Million) Table 140. Global Tenofovir Disoproxil Fumarate Production Value by Application (2027-2032) & (US$ Million) Table 141. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Application (2021-2026) Table 142. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Application (2027-2032) Table 143. Global Tenofovir Disoproxil Fumarate Price by Application (2021-2026) & (US$/pcs) Table 144. Global Tenofovir Disoproxil Fumarate Price by Application (2027-2032) & (US$/pcs) Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Tenofovir Disoproxil Fumarate Distributors List Table 148. Tenofovir Disoproxil Fumarate Customers List Table 149. Tenofovir Disoproxil Fumarate Industry Trends Table 150. Tenofovir Disoproxil Fumarate Industry Drivers Table 151. Tenofovir Disoproxil Fumarate Industry Restraints Table 152. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tenofovir Disoproxil Fumarate Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. 30 Pcs/Box Product Image Figure 7. 10 Pcs/Box Product Image Figure 8. HIV-1 Infection Product Image Figure 9. Chronic Hepatitis Product Image Figure 10. Others Product Image Figure 11. Global Tenofovir Disoproxil Fumarate Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tenofovir Disoproxil Fumarate Production Value (2021-2032) & (US$ Million) Figure 13. Global Tenofovir Disoproxil Fumarate Production Capacity (2021-2032) & (w pcs) Figure 14. Global Tenofovir Disoproxil Fumarate Production (2021-2032) & (w pcs) Figure 15. Global Tenofovir Disoproxil Fumarate Average Price (US$/pcs) & (2021-2032) Figure 16. Global Tenofovir Disoproxil Fumarate Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Tenofovir Disoproxil Fumarate Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tenofovir Disoproxil Fumarate Production Comparison by Region: 2021 VS 2025 VS 2032 (w pcs) Figure 20. Global Tenofovir Disoproxil Fumarate Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Tenofovir Disoproxil Fumarate Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Tenofovir Disoproxil Fumarate Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Tenofovir Disoproxil Fumarate Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Tenofovir Disoproxil Fumarate Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Tenofovir Disoproxil Fumarate Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Tenofovir Disoproxil Fumarate Consumption Comparison by Region: 2021 VS 2025 VS 2032 (w pcs) Figure 28. Global Tenofovir Disoproxil Fumarate Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 30. North America Tenofovir Disoproxil Fumarate Consumption Market Share by Country (2021-2032) Figure 31. United States Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 32. United States Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 33. Canada Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 34. Mexico Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 35. Europe Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 36. Europe Tenofovir Disoproxil Fumarate Consumption Market Share by Country (2021-2032) Figure 37. Germany Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 38. France Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 39. U.K. Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 40. Italy Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 41. Russia Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 42. Spain Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 43. Netherlands Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 44. Switzerland Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 45. Sweden Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 46. Poland Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 47. Asia Pacific Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 48. Asia Pacific Tenofovir Disoproxil Fumarate Consumption Market Share by Country (2021-2032) Figure 49. China Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 50. Japan Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 51. South Korea Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 52. India Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 53. Australia Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 54. Taiwan Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 55. Southeast Asia Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 56. South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 57. South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption Market Share by Country (2021-2032) Figure 58. Brazil Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 59. Argentina Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 60. Chile Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 61. Turkey Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 62. GCC Countries Tenofovir Disoproxil Fumarate Consumption and Growth Rate (2021-2032) & (w pcs) Figure 63. Global Tenofovir Disoproxil Fumarate Production Market Share by Type (2021-2032) Figure 64. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Type (2021-2032) Figure 65. Global Tenofovir Disoproxil Fumarate Price (US$/pcs) by Type (2021-2032) Figure 66. Global Tenofovir Disoproxil Fumarate Production Market Share by Application (2021-2032) Figure 67. Global Tenofovir Disoproxil Fumarate Production Value Market Share by Application (2021-2032) Figure 68. Global Tenofovir Disoproxil Fumarate Price (US$/pcs) by Application (2021-2032) Figure 69. Tenofovir Disoproxil Fumarate Value Chain Figure 70. Tenofovir Disoproxil Fumarate Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Tenofovir Disoproxil Fumarate Industry Opportunities and Challenges

Scope & coverage.

Types
  • 30 Pcs/Box
  • 10 Pcs/Box
Applications
  • HIV-1 Infection
  • Chronic Hepatitis
  • Others
Companies covered
  • Abbott
  • Qilu Pharmaceutical
  • Mylan Pharmaceuticals
  • Glaxo SmithKline
  • Chengdu Brilliant Pharmaceutical
  • Zydus Cadila
  • Wockhardt Ltd
  • Torrent Pharmaceuticals
  • Natco Pharma
  • Hetero Drugs
  • Gilead PHARMACARE
  • Emcure Pharmaceuticals
  • Dr Reddy's Laboratories
  • Cipla
  • CHIA TAI TIANQING (CTTQ) Pharmaceutical
  • Anhui Biochem Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Tenofovir Disoproxil Fumarate by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 30 Pcs/Box
  5. 2.2.3 10 Pcs/Box
  6. 2.3 Tenofovir Disoproxil Fumarate by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 HIV-1 Infection
  9. 2.3.3 Chronic Hepatitis
  10. 2.3.4 Others
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Tenofovir Disoproxil Fumarate Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Tenofovir Disoproxil Fumarate Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Tenofovir Disoproxil Fumarate Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tenofovir Disoproxil Fumarate Production by Manufacturers (2021-2026)
  2. 3.2 Global Tenofovir Disoproxil Fumarate Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Tenofovir Disoproxil Fumarate Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Tenofovir Disoproxil Fumarate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tenofovir Disoproxil Fumarate Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Tenofovir Disoproxil Fumarate Manufacturers, Product Type & Application
  7. 3.7 Global Tenofovir Disoproxil Fumarate Manufacturers Established Date
  8. 3.8 Global Tenofovir Disoproxil Fumarate Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Tenofovir Disoproxil Fumarate Company Information
  3. 4.1.2 Abbott Tenofovir Disoproxil Fumarate Business Overview
  4. 4.1.3 Abbott Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Qilu Pharmaceutical
  8. 4.2.1 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Company Information
  9. 4.2.2 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Business Overview
  10. 4.2.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  11. 4.2.4 Qilu Pharmaceutical Product Portfolio
  12. 4.2.5 Qilu Pharmaceutical Recent Developments
  13. 4.3 Mylan Pharmaceuticals
  14. 4.3.1 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Company Information
  15. 4.3.2 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Business Overview
  16. 4.3.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Pharmaceuticals Product Portfolio
  18. 4.3.5 Mylan Pharmaceuticals Recent Developments
  19. 4.4 Glaxo SmithKline
  20. 4.4.1 Glaxo SmithKline Tenofovir Disoproxil Fumarate Company Information
  21. 4.4.2 Glaxo SmithKline Tenofovir Disoproxil Fumarate Business Overview
  22. 4.4.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  23. 4.4.4 Glaxo SmithKline Product Portfolio
  24. 4.4.5 Glaxo SmithKline Recent Developments
  25. 4.5 Chengdu Brilliant Pharmaceutical
  26. 4.5.1 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Company Information
  27. 4.5.2 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Business Overview
  28. 4.5.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  29. 4.5.4 Chengdu Brilliant Pharmaceutical Product Portfolio
  30. 4.5.5 Chengdu Brilliant Pharmaceutical Recent Developments
  31. 4.6 Zydus Cadila
  32. 4.6.1 Zydus Cadila Tenofovir Disoproxil Fumarate Company Information
  33. 4.6.2 Zydus Cadila Tenofovir Disoproxil Fumarate Business Overview
  34. 4.6.3 Zydus Cadila Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  35. 4.6.4 Zydus Cadila Product Portfolio
  36. 4.6.5 Zydus Cadila Recent Developments
  37. 4.7 Wockhardt Ltd
  38. 4.7.1 Wockhardt Ltd Tenofovir Disoproxil Fumarate Company Information
  39. 4.7.2 Wockhardt Ltd Tenofovir Disoproxil Fumarate Business Overview
  40. 4.7.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  41. 4.7.4 Wockhardt Ltd Product Portfolio
  42. 4.7.5 Wockhardt Ltd Recent Developments
  43. 4.8 Torrent Pharmaceuticals
  44. 4.8.1 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Company Information
  45. 4.8.2 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Business Overview
  46. 4.8.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  47. 4.8.4 Torrent Pharmaceuticals Product Portfolio
  48. 4.8.5 Torrent Pharmaceuticals Recent Developments
  49. 4.9 Natco Pharma
  50. 4.9.1 Natco Pharma Tenofovir Disoproxil Fumarate Company Information
  51. 4.9.2 Natco Pharma Tenofovir Disoproxil Fumarate Business Overview
  52. 4.9.3 Natco Pharma Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  53. 4.9.4 Natco Pharma Product Portfolio
  54. 4.9.5 Natco Pharma Recent Developments
  55. 4.10 Hetero Drugs
  56. 4.10.1 Hetero Drugs Tenofovir Disoproxil Fumarate Company Information
  57. 4.10.2 Hetero Drugs Tenofovir Disoproxil Fumarate Business Overview
  58. 4.10.3 Hetero Drugs Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  59. 4.10.4 Hetero Drugs Product Portfolio
  60. 4.10.5 Hetero Drugs Recent Developments
  61. 4.11 Gilead PHARMACARE
  62. 4.11.1 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Company Information
  63. 4.11.2 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Business Overview
  64. 4.11.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  65. 4.11.4 Gilead PHARMACARE Product Portfolio
  66. 4.11.5 Gilead PHARMACARE Recent Developments
  67. 4.12 Emcure Pharmaceuticals
  68. 4.12.1 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Company Information
  69. 4.12.2 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Business Overview
  70. 4.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  71. 4.12.4 Emcure Pharmaceuticals Product Portfolio
  72. 4.12.5 Emcure Pharmaceuticals Recent Developments
  73. 4.13 Dr Reddy's Laboratories
  74. 4.13.1 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Company Information
  75. 4.13.2 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Business Overview
  76. 4.13.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  77. 4.13.4 Dr Reddy's Laboratories Product Portfolio
  78. 4.13.5 Dr Reddy's Laboratories Recent Developments
  79. 4.14 Cipla
  80. 4.14.1 Cipla Tenofovir Disoproxil Fumarate Company Information
  81. 4.14.2 Cipla Tenofovir Disoproxil Fumarate Business Overview
  82. 4.14.3 Cipla Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  83. 4.14.4 Cipla Product Portfolio
  84. 4.14.5 Cipla Recent Developments
  85. 4.15 CHIA TAI TIANQING (CTTQ) Pharmaceutical
  86. 4.15.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Company Information
  87. 4.15.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Business Overview
  88. 4.15.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  89. 4.15.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Product Portfolio
  90. 4.15.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Developments
  91. 4.16 Anhui Biochem Pharmaceutical
  92. 4.16.1 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Company Information
  93. 4.16.2 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Business Overview
  94. 4.16.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Production, Value and Gross Margin (2021-2026)
  95. 4.16.4 Anhui Biochem Pharmaceutical Product Portfolio
  96. 4.16.5 Anhui Biochem Pharmaceutical Recent Developments
5 Global Tenofovir Disoproxil Fumarate Production by Region
  1. 5.1 Global Tenofovir Disoproxil Fumarate Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tenofovir Disoproxil Fumarate Production by Region: 2021-2032
  3. 5.2.1 Global Tenofovir Disoproxil Fumarate Production by Region: 2021-2026
  4. 5.2.2 Global Tenofovir Disoproxil Fumarate Production Forecast by Region (2027-2032)
  5. 5.3 Global Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Tenofovir Disoproxil Fumarate Production Value by Region: 2021-2032
  7. 5.4.1 Global Tenofovir Disoproxil Fumarate Production Value by Region: 2021-2026
  8. 5.4.2 Global Tenofovir Disoproxil Fumarate Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Tenofovir Disoproxil Fumarate Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Tenofovir Disoproxil Fumarate Production and Value, YOY Growth
  11. 5.6.1 North America Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Tenofovir Disoproxil Fumarate Production Value Estimates and Forecasts (2021-2032)
6 Global Tenofovir Disoproxil Fumarate Consumption by Region
  1. 6.1 Global Tenofovir Disoproxil Fumarate Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tenofovir Disoproxil Fumarate Consumption by Region (2021-2032)
  3. 6.2.1 Global Tenofovir Disoproxil Fumarate Consumption by Region: 2021-2026
  4. 6.2.2 Global Tenofovir Disoproxil Fumarate Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tenofovir Disoproxil Fumarate Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tenofovir Disoproxil Fumarate Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Tenofovir Disoproxil Fumarate Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Tenofovir Disoproxil Fumarate Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Tenofovir Disoproxil Fumarate Production by Type (2021-2032)
  2. 7.1.1 Global Tenofovir Disoproxil Fumarate Production by Type (2021-2032) & (w pcs)
  3. 7.1.2 Global Tenofovir Disoproxil Fumarate Production Market Share by Type (2021-2032)
  4. 7.2 Global Tenofovir Disoproxil Fumarate Production Value by Type (2021-2032)
  5. 7.2.1 Global Tenofovir Disoproxil Fumarate Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tenofovir Disoproxil Fumarate Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Tenofovir Disoproxil Fumarate Production by Application (2021-2032)
  2. 8.1.1 Global Tenofovir Disoproxil Fumarate Production by Application (2021-2032) & (w pcs)
  3. 8.1.2 Global Tenofovir Disoproxil Fumarate Production Market Share by Application (2021-2032)
  4. 8.2 Global Tenofovir Disoproxil Fumarate Production Value by Application (2021-2032)
  5. 8.2.1 Global Tenofovir Disoproxil Fumarate Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Tenofovir Disoproxil Fumarate Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Tenofovir Disoproxil Fumarate Value Chain Analysis
  2. 9.1.1 Tenofovir Disoproxil Fumarate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Tenofovir Disoproxil Fumarate Production Mode & Process
  5. 9.2 Tenofovir Disoproxil Fumarate Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Tenofovir Disoproxil Fumarate Distributors
  8. 9.2.3 Tenofovir Disoproxil Fumarate Customers
10 Global Tenofovir Disoproxil Fumarate Analyzing Market Dynamics
  1. 10.1 Tenofovir Disoproxil Fumarate Industry Trends
  2. 10.2 Tenofovir Disoproxil Fumarate Industry Drivers
  3. 10.3 Tenofovir Disoproxil Fumarate Industry Opportunities and Challenges
  4. 10.4 Tenofovir Disoproxil Fumarate Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst